There is a strong body of evidence that points to the mental health and well‐being benefits of nature alongside a growing evidence based on the health and well‐being benefits of green social prescribing. Central to the UK government’s commitment to transform mental health services, seven successful ‘test and learn’ green social prescribing sites were identified across England, including the Humber and North Yorkshire green social prescribing programme. We used a cohort design to compare participants’ mental health and well‐being outcomes before and after exposure to nature‐based interventions offered via a referral from social prescribing organisations linked to the green social prescribing initiative. Data were collected between February 2022 and March 2023 using before and after questionnaires to determine the impact of green social prescribing on mental health and well‐being outcomes using ONS‐4 and Hospital and Anxiety Depression scales. In total, two hundred and twenty‐three participants from across Humber and North Yorkshire were included in the cohort evaluation. Survey data were analysed quantitatively using descriptive and multivariable analyses. After adjustments for deprivation and health status, larger benefits for improvements in well‐being were found to be associated with nature‐based activities with durations of nine to 12 weeks compared to those with durations of one to four weeks. Horticultural and care farming activities were also shown to be associated with some improvements in well‐being over nature‐based sports and exercise activities. We have undertaken the first longitudinal and quantitative evaluation of the NHS England green social prescribing “test and learn” programme across Humber and North Yorkshire. Our evaluation in Humber and North Yorkshire showed green social prescribing is beneficial for mental health and well‐being among community‐based adults, suggesting potential as a timely and relevant community‐based intervention to address the demand for mental health care in an era of high unmet need.
22 June 2024 in Humanities and Social Sciences Communications
Transdisciplinary co-produced health research and co-designed interventions have the capacity to improve research quality and the relevance, acceptability, and accessibility of healthcare. This approach also helps researchers to address power imbalances to share decision-making with service-users and the public. However, this growing methodology is currently difficult to appraise and develop as detailed sharing of practice is limited. The ‘CO-production of a Nature-based Intervention For children with ADHD study’ (CONIFAS) aimed to create a novel intervention with and for children with attention deficit hyperactivity disorder (ADHD) using co-production and co-design methodologies. This knowledge exchange paper will be of benefit to researchers with aspirations to undertake co-production, especially in the context of working with under-represented groups. Critical reflection on the use of co-production identified that every attempt was made to adequately resource the co-production, share power, value diversity, and develop trust. The team reflected that the re-conceptualisation of the role of the researcher in co-production can be challenging. Whilst the use of models of co-production provides a framework for study development, designing and running the specifics of the workshops, as well as how to effectively engage co-researchers in an equitable way, came from utilising clinical skills, networking, and creativity. These methods are particularly pertinent to involving neurodiverse children and their families who are under-represented in participatory research and in need of bespoke health interventions.
9 December 2024 in Children and Youth Services Review
Social prescribing connects people to community activities and services to meet practical, social and emotional needs affecting their health and wellbeing.
Background Child and adolescent mental health is a public health priority, and prevention, early intervention, and treatment are identified as national strategic priorities. Children and young people (CYP) in the United Kingdom are experiencing poorer mental health outcomes than ever, and the demand for services is the highest on record. Understanding the effectiveness of school-based interventions for promoting and developing emotional well-being is a core research priority. A school-based intervention that is inclusive and has the potential for widespread delivery is ‘Forest School’. Forest schools provide children with immersive experiences in nature that are non-classroom-based and have a core focus on child-led activities and exploration. Despite widespread implementation, evidence about optimal delivery methods for Forest Schools and their impact on mental health and emotional well-being is scarce. This study will generate new knowledge about the feasibility of running a definitive Forest School trial with Key Stage 2 (KS2) children aged between 7–11 inclusive of children with special educational needs and disabilities. Research Questions Is Forest School an acceptable and feasible intervention to improve the mental health of KS2 children? Is it feasible to run a cluster Randomised Controlled Trial (RCT) of Forest School for children in key stage 2 (aged 7–11)? Objectives 1. Test feasibility of trial procedures for recruitment, randomisation, and data collection 2. Conduct a mixed methods process evaluation to evaluate implementation and fidelity 3. Collect feasibility data to support an economic evaluation in a full trial 4. Refine the current logic model and optimise the intervention Methods In Work Package (WP) 1, we will conduct a feasibility cluster RCT of a Forest School intervention with 200 children in five schools across Hull, East Yorkshire, and North Yorkshire. We will test the acceptability and feasibility of intervention delivery, assess the feasibility of the trial processes, and establish key parameters for effectiveness. In WP2, we will evaluate the quality and fidelity of intervention delivery through process evaluation, including observations and qualitative interviews. WP3 focused on the preliminary collection of health economic data. WP4 uses focus groups to refine the logic model and optimize the content of the intervention. We seek to produce a manualised toolkit informed by interconnected work packages to inform further research and implementation. The trial was registered in ISRCTN (The United Kingdom’s Trial Registry). Clinical Trials Registration Number ISRCTN87263624. Patient and Public Involvement This proposal was developed with the active involvement of parents/guardians, children, and schools alongside key stakeholders from the local authority, education, and the community sector. Dissemination We will develop accessible presentations, online workshops with interactive elements, and newsletters. Producing a set of easily read infographics and creative outputs (video/social media) alongside our children’s Patient and Public Involvement (PPI) groups will be a key output. We anticipate that two publications in open-access peer-reviewed journals will share the quantitative and qualitative findings of the study.
Digital ecosystems shape human health, cognition, socialisation, entertainment, and harm. However, research into these environments is constrained by a data gap. The behavioural records needed to study digital life are largely siloed inside corporate systems. This creates an asymmetry. Companies often hold the data needed to understand the impacts of their own technologies, but are conflicted by commercial interests. Conversely, independent researchers are often relatively unconflicted but lack access to usable data. In this paper, we describe the Smart Data Donation Service (SDDS): national research infrastructure designed to address this gap. The SDDS enables individuals to donate copies of their digital trace data for public good research using secure, low-friction tools; deploys these tools into both pre-existing cohorts and novel recruitment streams; transforms the resulting data into research-ready data products; and surfaces these products through mechanisms which preserve participant trust and privacy. We argue that the SDDS provides a route for breaking corporate data monopolies, mainstreaming data donation methods, and enabling the resulting outputs to be widely used in public-interest research without creating undue privacy risks or stewardship burdens.